Viking Therapeutics, Inc. VKTX
25.84 USD -0.33 (-1.26%)
Regular-session close
25.59 -0.25 -0.97%
Pre-market · Nov 20, 4:00 AM ET
25.56 Day range 26.76
23.82 52-week range 43.10
- YTD
- -26.55%
- 1 year
- -28.30%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -393.34M | -150.92M | -100.83M | -70.36M | -55.68M | |
| -359.64M | -109.96M | -85.89M | -68.87M | -54.99M | |
| -3.19 | -1.01 | -0.91 | -0.90 | -0.71 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 165.86M | 26.72M | 55.55M | 36.66M | 26.40M | |
| 715.73M | 908.32M | 368.49M | 168.53M | 210.66M | |
| 76.67M | 28.04M | 20.07M | 23.21M | 8.78M | |
| 137.00K | 1.12M | 1.26M | 1.56M | 29.00K | |
| 639.06M | 880.28M | 348.42M | 145.32M | 201.88M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -278.69M | -87.79M | -73.38M | -48.40M | -47.59M | |
| 341.39M | -553.37M | -179.09M | 54.75M | 37.96M | |
| 76.44M | 612.46M | 271.38M | 4.16M | 6.88M | |
| 139.14M | -28.69M | 18.91M | 10.52M | -2.75M |
